ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Trilliant Health Launches New Premium Research Subscriptions

Trilliant Health releases premium research subscriptions to equip healthcare executives with detailed and tailored insights on emerging healthcare trends.

In contrast to survey-based methods, Trilliant Health’s approach combines academic rigor with the industry’s most powerful dataset to offer data-driven insight.

Trilliant Health, the healthcare industry’s leading analytics and market research firm, today announced the public launch of premium research subscriptions with exclusive research, educational materials and strategic planning resources. Trilliant Health’s premium research combines academic rigor with the industry’s most powerful datasets to set a new standard for data-driven insights, with medical and pharmacy claims for more than 300 million Americans and negotiated rates for health plans across the country.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230713964288/en/

Preview of Trilliant Health's Compass+ research platform (Photo: Business Wire)

Preview of Trilliant Health's Compass+ research platform (Photo: Business Wire)

“The health economy creates more data than any other part of the economy. Yet, the industry has been satisfied with data that is ‘directionally correct,’ based primarily on surveys with small sample size,” said Trilliant Health’s Chief Research Officer, Sanjula Jain, Ph.D. “Even in academia, our ability to draw conclusions is often limited by the scale and quality of available data. At Trilliant Health, our vision is to create comprehensive, data-driven research as a guide for industry leaders to navigate the increasingly complex health economy.”

The new subscriptions expand on publicly available research, including Trilliant Health’s industry-recognized publication, The Compass, which is read by C-suite and senior executives across all segments of the health economy from health systems to life sciences. Subscribers can access the Compass+ platform for:

  • Health Economy Trends: includes emerging and evolving trends with access to an expanded weekly research publication, in-depth reports with stakeholder-specific commentaries, a presentation-ready slide repository and quarterly policy insights.
  • Strategic Insights: includes a monthly publication, primers on essential strategy concepts, overviews of stakeholder priorities and a collection of conversations with senior industry executives.
  • Data Tracking: provides forecasts for national trends in utilization and supply with interactive dashboards.

“I love The Compass. I look forward to every issue because I know I will learn something new,” said Robert Groves, M.D., Executive Vice President and Chief Medical Officer of Banner | Aetna. “It’s not an opinion piece, or a retread of the familiar ‘expert’ narratives, but rather a concise delivery of research-based, data-driven insights. These unique insights, in turn, drive true evidence-based strategy.”

Trilliant Health’s publicly available research, from The Compass and Trends Shaping the Health Economy report series to the SimilarityIndex™ | Hospitals benchmarking analysis, has been at the forefront of helping healthcare executives quantify and contextualize how the industry is changing by examining the demand (i.e., patient, consumer), supply (i.e., providers) and yield (i.e., price, cost of care) for any given topic. Trilliant Health’s research spans the organization, financing and delivery of healthcare and includes topics such as behavioral health, telehealth, the impact of retail providers, total cost of care by service line, physician practice and prescribing patterns, to name a few.

“In this time of unprecedented challenges, it is more important than ever for us to anticipate the health care needs of the communities we serve, the evolving needs of our consumers and the forces impacting our industry,” said David Banks, Chief Strategy Officer for AdventHealth. “Trilliant Health’s research and reports on real-time trends have become a valuable resource as we develop and execute strategies to deliver whole person care to more patients and communities.”

“In response to all of the public research we have been publishing these past few years, our research team has been supporting executive teams by answering questions about the impact of individual trends for specific markets, organizations and patient populations. Through these follow-up projects, a common theme of research questions and information needs became apparent, resulting in the creation of tailored research subscriptions from the Compass+ and Service Line Intelligence Reports to Performance Evaluation and Benchmarking,” said Jain.

Learn more about Trilliant Health’s premium research subscriptions: https://www.trillianthealth.com/premium-research-subscriptions

About Trilliant Health

Trilliant Health combines healthcare industry expertise, market research and predictive analytics to form Evidence-Based Strategy for Healthcare™. Trilliant Health's proprietary analytics platform produces a comprehensive understanding of local market dynamics providing exponentially better data insights to maximize returns from growth strategies.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.